Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit is a research paper published in Journal of Thoracic Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P30CA068485
National Institutes of Health
Grant: P50CA098131
National Institutes of Health
Grant: P50CA236733
National Institutes of Health
Grant: U24CA163056
National Institutes of Health
Grant: U24CA213274
National Institutes of Health
Grant: U54CA163072
Ministry of Science and Technology, Taiwan
Grant: MOST107-2314-B-002-231
Ministry of Science and Technology, Taiwan
Grant: MOST108-2314-B-002-197-MY2
Ministry of Science and Technology, Taiwan
Grant: MOST108-2314-B-030-014
Ministry of Science and Technology, Taiwan
Grant: MOST109-2314-B-038-150
Taipei Medical University
Grant: 110TMU-TMUH-02-5
Taipei Medical University
Grant: DP5-111-21314-07
Taipei Medical University
Grant: TMU110-AE1-B13
National Health Research Institutes
Grant: NHRI-EX109-10937BC
National Health Research Institutes
Grant: NHRI-EX110-10937BC
National Health Research Institutes
Grant: NHRI-EX111-10937BC
FWCI
0.09
Citation Percentile
0.4%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals